Literature DB >> 7254442

Nephrotic syndrome in Hodgkin's disease. Report of five cases and review of the literature.

P Kramer, W Sizoo, E E Twiss.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7254442

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  7 in total

1.  Frequently relapsing minimal change nephrotic syndrome with natural killer cell deficiency prior to the overt relapse of Hodgkin's disease.

Authors:  T Mori; A Yabuhara; J Nakayama; M Kitahara; K Washizawa; S Kasai; A Komiyama
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

2.  Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin.

Authors:  Gian Marco Ghiggeri; Dario Bleid; Alberto Garaventa; Cristina Coccia; Claudio Gambini; Gianluca Caridi; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2007-11-20       Impact factor: 3.714

3.  Glomerulonephritis preceding late relapse of Hodgkin's disease.

Authors:  W A Lynn; R E Marcus
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

4.  Minimal change disease associated with anti-PD1 immunotherapy: a case report.

Authors:  Bixia Gao; Ningjing Lin; Suxia Wang; Yu Wang
Journal:  BMC Nephrol       Date:  2018-07-03       Impact factor: 2.388

5.  Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy.

Authors:  Valerie Glutsch; Franziska Grän; Judith Weber; Anja Gesierich; Matthias Goebeler; Bastian Schilling
Journal:  J Immunother Cancer       Date:  2019-07-12       Impact factor: 13.751

Review 6.  Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits.

Authors:  Antoine Morel; Marie-Sophie Meuleman; Anissa Moktefi; Vincent Audard
Journal:  Diagnostics (Basel)       Date:  2021-04-15

7.  Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.

Authors:  Sakue Masuda; Kazuya Koizumi; Hidekazu Moriya; Takashi Nishino; Haruki Uojima; Tomohiko Tazawa; Karen Kimura; Junichi Tasaki; Chikamasa Ichita; Akiko Sasaki; Makoto Kako; Sumi Hidaka; Madoka Kudo
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.